Purpose: The purpose of this study was to report the association of phenotypic features characteristic of lattice corneal dystrophy (LCD) with a monoclonal gammopathy of undetermined significance (MGUS) after exclusion of a coding region mutation in transforming growth factor beta-induced (TGFBI) gene.
Results: A 65-year-old man demonstrated bilateral linear branching corneal stromal opacities characteristic of classic LCD. No mutations were found in any of the 17 exons of TGFBI or in the intron-exon boundary regions. Four previously described single nucleotide polymorphisms were identified: c.698C.G (p.Leu217Leu; rs1442), c.1028A.G (p.Val327Val; rs1054124), c.1416C.T (p.Leu472Leu; rs1133170), and c.1667T.C (p.Phe540Phe; rs4669). Serum protein electrophoresis revealed the presence of a monoclonal spike, and based on the results of additional investigations, the patient was diagnosed with MGUS.
Conclusions:
Although the presence of bilateral thin branching lattice lines in the corneal stroma is characteristic of classic LCD, this distinctive phenotype may not be associated with a TGFBI coding region mutation but instead with a myeloproliferative disorder such as MGUS. Therefore, appropriate genetic and serologic testing should be performed in patients with a late-onset LCD phenotype in the absence of a positive family history. Classic and variant lattice corneal dystrophies (LCDs) are manifestations of primary localized corneal amyloidosis associated with a number of mutations in the transforming growth factor beta-induced (TGFBI) gene on chromosome 5q31. 1 Traditionally, the diagnosis has been made based on characteristic clinical features and a positive family history. However, several reports of nondystrophic localized causes of corneal lattice lines published in the past several years have highlighted the usefulness of genetic testing to differentiate between dystrophic and nondystrophic disorders demonstrating phenotypic features previously associated only with classic LCD. 2, 3 We report a case of a patient demonstrating clinical features characteristic of classic LCD in which screening of TGFBI excluded the possibility of a previously described or novel coding region mutation. Evaluation for systemic disorders associated with systemic amyloidosis revealed a monoclonal gammopathy of undetermined significance (MGUS), which we report in association with a pseudo-classic LCD phenotype.
CASE REPORT
A 65-year-old white man was referred to one of the authors (A.J.A.) for evaluation of bilateral corneal deposits that resembled stromal lattice lines. The patient complained of difficulty with glare for 5 years before presentation. As no mention of a corneal abnormality was made when the patient had an eye examination 4 years before presentation or when he had cataract extraction 18 months before presentation, he was first diagnosed with corneal deposits that appeared consistent with LCD when he was examined 1 year before presentation. The patient denied a history of contact lens wear, ocular trauma, or corneal erosions. Although no family members were available for examination, the patient denied a family history of corneal disorders.
A hematologic evaluation to differentiate between primary and secondary corneal amyloidosis revealed a slightly elevated quantitative serum immunoglobulin (Ig) G level of 1.66 g/dL (normal, 0.69-1.62 g/dL). Serum protein electrophoresis revealed a monoclonal protein spike, and an immunofixation test showed the presence of IgG and IgM monoclonal gammopathy, although Bence Jones protein was not detected in the urine. Based on these results, the patient was diagnosed with MGUS.
On presentation to one of the authors (A.J.A.), best-corrected visual acuities measured 20/25 OD and 20/30 OS. Thin branching anterior stromal lattice lines involved both the central and the peripheral portions of each cornea, accompanied by focal polymorphic deposits that appeared gray-white on direct illumination and translucent on retroillumination (Fig. 1) . The mid and posterior corneal stroma was clear in each eye, and neither cornea demonstrated superficial or stromal vascularization.
After informed consent was obtained from the patient, DNA was collected for polymerase chain reaction amplification and direct sequencing of TGFBI exons 1-17, which were performed as described previously. 4 No presumed pathogenic mutations were identified, although 4 previously described single nucleotide polymorphisms were: c.698C.G (p.Leu217Leu; rs1442), c.1028A.G (p.Val327Val; rs1054124), c.1416C.T (p.Leu472Leu; rs1133170), and c.1667T.C (p.Phe540Phe; rs4669).
COMMENT
MGUS is defined as an asymptomatic, premalignant disorder characterized by monoclonal plasma cell proliferation in the absence of end-organ damage. Although MGUS is considered one of the plasma cells dyscrasias, which are associated with systemic amyloidosis and abnormal corneal deposits in varied morphologic patterns, 5 corneal deposits are rarely observed in patients with MGUS. To the best of our knowledge, corneal lattice lines have been reported in only 2 patients with MGUS, 6, 7 and in neither case was screening of TGFBI performed to definitively exclude a classic or variant form of a TGFBI-associated corneal dystrophy.
Although the authors have observed and reported several cases of pseudo-LCD associated with localized causes, 2,3 this case describes a rare systemic cause of the LCD phenotype. We recommend that TGFBI screening be performed in patients without a family history of LCD who present with a classic LCD phenotype. If a causative mutation is not identified, such patients should undergo an evaluation for systemic conditions associated with secondary corneal amyloid deposition. 
